Pharmacogenotyping of CYP3A5 in predicting dose-adjusted trough levels of tacrolimus among Malaysian kidney-transplant patients
Tacrolimus (FK506) is a calcineurin inhibitor with a narrow therapeutic index that exhibits large interindividual variation. Seventy-eight kidney transplant patients treated with tacrolimus were recruited to study the correlation of dose adjusted trough level (level/dose; L/D) of tacrolimus with CYP...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Published: |
NRC Research Press
2014
|
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|